Production and application of 177Lu-PSMA and 225Ac-PSMA in the sustainable innovation model through Balanced Scorecard (BSC)
Carregando...
Data
Data de publicação:
2023
Orientador
Título da Revista
ISSN da Revista
Título do Volume
É parte de
É parte de
É parte de
É parte de
INTERNATIONAL SYMPOSIUM ON TRENDS IN RADIOPHARMACEUTICALS
Exportar
Resumo
177Lu-PSMA and 225Ac-PSMA appear in the theranostic concept, with astonishing results in
prostate cancer patients, who did not respond to conventional therapies. In Europe, these
treatments are used successfully. However, in Brazil, 30% of patients do not respond well to new
radiopharmaceuticals, requiring broader studies.
The "Multicenter program using PSMA radioligands for diagnosis and therapy of patients with
prostate cancer", in which this research project is inserted, in partnership among the Nuclear and
Energy Research Institute (IPEN-CNEN), a private company and associated institutions, aims to
expand the therapeutic alternatives for patients with cancer unresponsive to the treatments
available in the public health network in the State of São Paulo.
IPEN-CNEN will produce the radiopharmaceuticals that will be distributed to Public Hospitals
responsible for the selection, treatment and follow-up of patients with metastatic castrationresistant
prostate cancer (mCPRC), and for the genetic and molecular characterization of patients
unresponsive to treatment.
The present research will study the technical and economic feasibility in the production and
application of these radiopharmaceuticals, with clinical studies in patients with mCPRC, applying
the Balanced Scorecard (BSC) management tool, measuring its performance by indicators aiming
at a strategic and efficient management, with the possibility of theirs marketing.
Como referenciar
SANTOS, KATIA C.; BERNARDES, EMERSON S.; CALVO, WILSON P. Production and application of 177Lu-PSMA and 225Ac-PSMA in the sustainable innovation model through Balanced Scorecard (BSC). In: INTERNATIONAL SYMPOSIUM ON TRENDS IN RADIOPHARMACEUTICALS, April 17-21, 2023, Vienna, Austria. Abstract... Vienna, Austria: International Atomic Energy Agency - IAEA, 2023. p. 173-173. Disponível em: http://repositorio.ipen.br/handle/123456789/34546. Acesso em: 09 May 2024.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.